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According to the literature, about 10–15% of stroke
patients expired during hospitalization before clinical
application of thrombolysis was available for acute
ischemic stroke [1]. Since 1996, after the benefits of
intravenous (IV) and intra-arterial (IA) thrombolytic
therapy within the critical time windows of 3 and 6
hours, respectively, were recognized, hyperacute stroke
has become an advanced concept and current issue.
However, preliminary results suggested that throm-
bolytic therapy just improved functional outcome, but
not mortality from all causes, and the relatively small
percentage of patients receiving thrombolysis might
have only a modest impact on hospital mortality [2].
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In the era of thrombolytic therapy for hyperacute ischemic stroke, most investigators have focused
their attention on the factors influencing mortality and functional outcomes in patients treated
with thrombolysis, but very few have focused on these factors among patients not receiving
thrombolysis. The aim of this study was to investigate the prognostic factors for mortality in all
hyperacute stroke patients with or without thrombolysis. In 2005, we enrolled 101 ischemic stroke
patients (43 females, 58 males; mean age, 68 years) who were transported to the emergency depart-
ment (ED) within 4 hours of symptom onset. The overall in-hospital mortality rate was 17.8%
(18/101). According to t test analysis, age (p = 0.034), time interval from neurologist consultation
(p < 0.0001) and ED to ward admission (p = 0.001), Glasgow coma scale (GCS) (p = 0.001), National
Institutes of Health Stroke Scale (NIHSS) (p < 0.0001) and the sum of major risk factors of cere-
brovascular disease (CVD) (p < 0.0001) were significantly different between mortality and survivor
groups. Further χ2 test analysis revealed significant differences in the presenting consciousness
disturbance (p = 0.001), place of attack (p = 0.04), and referral transportation (p = 0.008) between
these groups. In conclusion, old age, delay between neurologist consultation and ward admission,
severity of stroke, and multiple risk factors of CVD are significant risk factors for in-hospital mor-
tality. Conversely, being free of initial consciousness disturbance, living in an urban area, and
having direct transportation to a stroke center are protective factors in survivors. The concept of
“brain attack” should be re-emphasized among ED physicians. The interconnection between
stroke centers and emergency medical systems (EMS) should be more tightly built to promote
timely management for hyperacute stroke care.
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Several studies and recent Cochrane Collaboration
meta-analyses have shown that more systematic stroke
care improves efficiency, and reduces death and long-
term institutionalization in patients admitted to stroke
units [3]. In 2000, the Brain Attack Coalition (BAC),
developed from a group of major professional organi-
zations, published recommendations to establish min-
imal criteria for acute stroke centers with the goal of
promoting timely administration of thrombolysis and
improving stroke care [4]. Afterwards, many studies
investigated the factors predictive of in-hospital mortal-
ity in acute stroke patients with thrombolysis [5–10].
Recently, two large national investigations found
that in-hospital mortality from acute ischemic stroke
was about 7.0% in academic medical centers (range,
2–12%) and 4.9% in community hospitals [11,12].
However, very few studies have evaluated the fac-
tors influencing mortality or functional outcomes in
all hyperacute stroke patients with or without throm-
bolysis. As acute stroke team members in an academic
hospital, we attempted to investigate the potential
protective and risk factors for in-hospital mortality in
all hyperacute ischemic stroke patients.
MATERIALS AND METHODS
We set up a strict stroke code for patients with hyper-
acute stroke who were transported to our ED within
4 hours of the onset of stroke symptoms. Because IA
thrombolysis requires much more preparation time
than IV thrombolysis, 4 hours after stroke onset was
the cut-off point in our study. For a period in 2005,
consecutive patients activating the stroke code were
registered prospectively [13].
Data included demographic features (sex, age,
education level, residence), clinical information (initial
presenting symptom and vital signs, time of symp-
tom onset, hospital arrival, neurologist consultation,
brain computed tomography (CT) performance, GCS,
NIHSS, and laboratory data), and transportation mode
(EMS, referral, other) were recorded. In addition, other
variables including major risk factors of CVD, stroke
territory, length of hospitalization and discharge status
were collected from chart recording.
The major risk factors of CVD, including old age,
history of stroke or transient ischemic attack (TIA),
ischemic heart disease, atrial fibrillation, diabetic melli-
tus (DM), hypertension, hyperlipidemia and smoking,
were noted for summation and well-documented [14].
Old age was defined as being older than 55 years and
50 years in females and males, respectively.
We categorized the stroke territory in all patients
based on the neuroradiologist’s report into five items:
anterior cerebral artery (ACA), middle cerebral artery
(MCA), internal carotid artery (ICA), posterior cere-
bral artery (PCA), and vertebral-basilar artery (VB).
Only ICA territory was recorded under the situation
when ipsilateral ACA and MCA were concomitantly
involved.
Patients with hyperacute ischemic stroke were
grouped into survivor and mortality cases according
to discharge status. In-hospital mortality was defined
as death from all causes on discharge from the acute
hospital.
Influential factors between mortality and survivor
groups that were presented as continuous variables
were analyzed by the Student’s t test. We used the χ2
test to analyze the categorical variables for detecting
risk and protective factors in enrolled patients. All
statistical analyses were conducted with SPSS ver-
sion 8.0 (SPSS Inc., Chicago, IL, USA), with statistical
significance set at p < 0.05 (2-sided).
RESULTS
We enrolled 101 patients with hyperacute ischemic
stroke, including 43 females and 58 males with a mean
age of 68 years (range, 36–91 years). The clinical char-
acteristics of the enrolled patients are summarized in
Table 1. Eighty-two patients suffered an attack in an
urban area and 19 patients suffered an attack in a rural
area. The proportions of patients transported to the ED
via EMS and following referrals from other hospitals
were 32.7% (33/101) and 15.8% (16/101) respectively.
Only 12 (11.9%) patients received IV tissue plasmin-
ogen activator (t-PA) or IA urokinase thrombolytic
therapy, and two patients (both post-IV t-PA) died dur-
ing acute hospitalization. The number of cases of in-
hospital all-cause mortality in hyperacute ischemic
stroke patients was 18 (17.8%).
The relative proportions of involvement of each
involved vascular territory in ischemic stroke were as
follows: ACA 2.83% (3/106), MCA 73.58% (78/106),
ICA 5.66% (6/106), PCA 4.71% (5/106), and VB system
13.2% (14/106). There were five patients with two dis-
tinctive territories. Overall, 84 (83.2%) and 17 (16.8%)
patients were respectively categorized as showing
anterior- and posterior-circulation involvement.
We also evaluated differences in demography,
clinical characteristics and influential factors between
mortality and survivor groups (Tables 2 and 3). The
mean age was 73.2 ± 10.2 years in mortality cases and
67.1±11.6 years in survivor cases (p=0.034). The mean
time intervals from ED presentation to neurologist
consultation and ward admission were 132±96.7 and
233.2±116.3 minutes, respectively, in the mortality
group, and 10.2 ± 8.6 and 112.3 ± 74.1 minutes, respec-
tively, in the survivor group (p < 0.0001 and p = 0.01).
In the mortality group, the mean GCS and NIHSS
scores were 9.6 ± 4.2 and 22.5 ± 8.7, respectively; in the
survivor group, these were 13.5 ± 2.6 and 9.5 ± 8.1
(p = 0.001 and p < 0.0001) respectively. Furthermore,
the mean sum of major risk factors in mortality cases
was 3.9 ± 1.0 and that in survivor cases 2.8 ± 1.2
(p < 0.0001) (Table 2). According to t tests, age, time
interval of ED presentation to a neurologist and ward
admission, GCS, NIHSS and the sum of major risk
factors were significantly different (p < 0.05) between
mortality and survivor groups.
From χ2 analysis, further significant differences
were revealed between mortality and survivor groups
in initial consciousness disturbance (p = 0.001), place
of attack (p=0.04), and referral transportation (p=0.008)
(Table 3). In the survivor group, 85.5% (71/83) of
patients had initial symptom onset in an urban area.
The mortality rates in rural and urban areas were
36.8% (7/19) and 13.4% (11/82), respectively. Most of
the patients in the survival group, 89.2% (74/83), were
not transported via referral hospital, and patients with
referral transportation had mortality rates of 43.8%
(7/16) versus 12.9% (11/85) in those without referral
transportation. Only 14 patients (16.9%) in the sur-
vivor group had an initial consciousness disturbance,
compared with 69 patients (83.1%) without conscious-
ness change. The patients that did not present with
consciousness disturbance had a survival rate of
89.6% (69/77). The mortality rate was 41.7% (10/24)
in patients with consciousness disturbance.
DISCUSSION
The in-hospital mortality and functional outcome in
acute stroke vary according to different stroke type,
severity and enrolled criteria in different dimensions.
In Steiner and Brainin’s investigation of data from
the Austrian Stroke Registry for acute stroke units
(which enrolled patients within 24 hours after symp-
tom onset), the overall stroke-unit mortality was about
6.8% [15]. In another study in the USA, the in-hospital
mortality rate of acute ischemic stroke patients was
about 2–12% in academic hospitals, without clear
inclusion criteria for time [11]. According to previous
thrombolysis trials, the 3-monthly mortality rates in
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Table 1. Demographic and clinical characteristics of
enrolled patients*
Age (yr) 68.2 ± 11.6
Sex
Female 43 (42.6)
Male 58 (57.4)
Education (yr)
Illiterate 25 (24.8)
≤ 9 51 (50.4)
> 9 25 (24.8)
Thrombolytic therapy, IV/IA 12, 10/2 (11.9)
Mortality 18 (17.8)
Thrombolysis (both IV t-PA) 2 (2.0)
Non-thrombolysis 16 (15.8)
GCS 12.8 ± 3.3
NIHSS 11.8 ± 9.5
Distribution of stroke territory
ACA 3 (2.8)
MCA 78 (73.6)
ICA 6 (5.7)
PCA 5 (4.7)
VB 14 (13.2)
Sum of risk factors†
≤ 2 40 (39.6)
3 28 (27.7)
4 20 (19.8)
≥ 5 13 (12.9)
Place of attack
Urban 82 (81.2)
Rural 19 (18.8)
Mode of transportation
EMS 33 (32.7)
Referral 16 (15.8)
Other 52 (51.5)
*Data presented as mean ± standard deviation or n (%); †risk
factors for ischemic stroke included old age, history of stroke
or transient ischemic attack, ischemic heart disease, atrial fibril-
lation, diabetes mellitus, hypertension, hyperlipidemia, smok-
ing. GCS = Glasgow Coma Scale; NIHSS = National Institutes
of Health Stroke Scale; EMS = emergency medical system.
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placebo groups vs. treatment groups were 21% versus
17% in the IV t-PA trial (≤ 3 hours), and about 3.5–27%
versus 5.3–25% in the IA thrombolysis trial (≤ 6 hours)
[2,16,17]. In our study, the overall in-hospital mortality
from all causes in hyperacute ischemic stroke patients
(≤ 4 hours) was 17.8% (18/101), suggesting that there
are still many factors influencing the mortality rate in
our series.
In order to predict mortality and outcome in acute
stroke patients, various measures have been estab-
lished according to stroke subtype etiology and severity
[18,19]. In general, our results in Table 2 are compatible
with those of many previous studies, showing that the
mortality group has advanced age [20], higher GCS
and NIHSS with serious stroke severity [21–23], and
more CVD risk factors [18,24].
In this study, there was an obvious time delay 
in neurologist consultation at the ED (132.7 ± 96.8 vs.
10.2 ± 8.6 minutes), as well as in transferal to the neu-
rological ward (233.2 ± 116.3 vs. 112.3 ± 74.1 minutes)
between these two groups. The reasonable explana-
tion for this is that the ED physician spent more time
managing the initial unstable vital signs and in making
the differential diagnosis in severe stroke patients.
Evidently, those patients free of consciousness
disturbance had significantly higher survival rates
than those presenting with consciousness disturbance
(69/77, 89.6% vs. 14/24, 58.3%), because they were
considered to have milder stroke severity and less
complicated illness. In the mortality group, there was
a high rate of initial consciousness disturbance (10/18,
55.6%). These patients usually showed greater clinical
severity, and were supposed to undergo many labo-
ratory, image exams and multidisciplinary consulta-
tions at the ED. These results are also supported by
some prior literature [18,25,26]. Besides, we noted
that the patients with initial speech disorder (includ-
ing dysphasia or dysarthria) had a lower risk for in-
hospital mortality (2/40, 5%). We thought this might
be due to under-reporting of the concomitant speech
problem in unconscious patients, and the number of
cases with a speech disorder in the mortality group
might be under-estimated. Another possibility is a
lower stroke severity in those patients presenting only
with dysphasia or dysarthria.
Patients living in urban areas had higher survival
rates than those living in rural areas (71/82, 86.6% vs.
12/19, 63.2%). It is understandable that there are more
available medical facilities and more convenient trans-
portation in urban areas. Patients visiting the ED via
direct transportation had markedly increased survival
rates compared with patients with arriving following
referral (74/85, 87.1% vs. 9/16, 56.3%). We presumed
that these patients might have worse clinical manifes-
tations, and needed further transfer to a medical center
for better management.
Table 2. Influential factors for in-hospital mortality in hyperacute ischemic stroke
Variable Mortality (n = 18) Survivor (n = 83) p*
Age (yr) 73.2 ± 10.2 67.1 ± 11.6 0.034
Time interval (min)
Onset to ED 116.6 ± 78.6 93.0 ± 59.7 0.270
ED to neurologist 132.7 ± 96.8 10.2 ± 8.6 < 0.0001
ED to CT 31.1 ± 23.5 22.1 ± 12.5 0.238
ED to ward 233.2 ± 116.3 112.3 ± 74.1 0.001
Initial BP (mmHg)
SBP 165.0 ± 33.4 157.9 ± 32.2 0.421
DBP 88.3 ± 23.1 90.0 ± 19.9 0.765
Severity
GCS 9.6 ± 4.2 13.5 ± 2.6 0.001
NIHSS 22.5 ± 8.7 9.5 ± 8.1 < 0.0001
Blood sugar on admission (mg/dL) 159.5 ± 58.6 138.3 ± 53.4 0.183
Sum of risk factors 3.9 ± 1.0 2.8 ± 1.2 < 0.0001
Hospitalization (d) 9.3 ± 7.0 11.6 ± 8.5 0.239
*t test. GCS = Glasgow Coma Scale; NIHSS = National Institutes of Health Stroke Scale.
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In our series, there were still some influential fac-
tors, such as initial systolic and diastolic blood pressure,
blood sugar and days of hospitalization; combining
these influential factors, age above 65, education level,
and presentation of weakness, and stroke territory
showed no significant difference. These results are not
compatible with those of previous studies. The rea-
son for this might be related to small case numbers 
in these variables. In order to solve this limitation of
our study, we expect that the Taiwan Stroke Registry
for acute stroke enrollment could answer the above
questions.
In conclusion, old age, delays in consultation by the
attending neurologist and ward admission, severity
of stroke (initial GCS and NIHSS), and multiple CVD
risk factors are significant risk factors for in-hospital
mortality. Conversely, being free of initial conscious-
ness disturbance at ED presentation, living in an urban
area, and having direct transportation to a stroke cen-
ter are strongly protective factors for survival cases.
The concept of “brain attack” should be re-emphasized,
particularly among ED physicians either in academic
or community hospitals. The interconnection between
stroke centers and local EMS should be more tightly
Table 3. Risk and protective factors between mortality and survivor groups
Variable Mortality, n (%) Survivor, n (%) p*
Age (yr) 0.116
≥ 65 14 (77.8) 47 (56.6)
< 65 4 (22.2) 36 (43.4)
Sex 0.601
Female 9 (50) 34 (41.0)
Male 9 (50) 49 (59.0)
Education 0.140
Literate 11 (61.1) 65 (78.3)
Illiterate 7 (38.9) 18 (21.7)
CVD PH 0.594
Yes 8 (44.4) 30 (36.1)
No 10 (55.6) 53 (63.9)
Initial symptoms
Consciousness disturbance 0.001
Yes 10 (55.6) 14 (16.9)
No 8 (44.4) 69 (83.1)
Weakness 0.158
Yes 10 (55.6) 61 (73.5)
No 8 (44.4) 22 (26.5)
Speech disorder 0.007
Yes 2 (11.1) 38 (45.8)
No 16 (88.9) 45 (54.2)
Territory 0.479
Anterior circulation 14 (77.8) 70 (84.3)
Posterior circulation 4 (22.2) 13 (15.7)
Place of attack 0.040
Urban 11 (61.1) 71 (85.5)
Rural 7 (38.9) 12 (14.5)
Referral 0.008
Yes 7 (38.9) 9 (10.8)
No 11 (61.1) 74 (89.2)
*χ2 test. CVD PH = past history of cerebrovascular disease and cardiovascular disease.
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integrated to promote timely management in hyper-
acute stroke care.
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